Diabetes and insulin resistance in pediatric obesity

Pediatric Clinics of North America

Volumn 58, Issue 6, 2011, Pages 1355-1361

  Kim, Grace ^a   Caprio, Sonia ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Insulin resistance; Pediatric obesity

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; INCRETIN; INSULIN; MEGLITINIDE; METFORMIN; PLACEBO; SULFONYLUREA;

ADIPOGENESIS; AUTOIMMUNITY; BEHAVIOR MODIFICATION; BODY FAT DISTRIBUTION; CLINICAL FEATURE; DIET THERAPY; DISEASE ASSOCIATION; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LIPID STORAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PSYCHOSOCIAL CARE; REVIEW;

ADOLESCENT; BODY FAT DISTRIBUTION; CHILD; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HUMANS; METABOLIC SYNDROME X; OBESITY;

EID: 81255211561     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2011.09.002     Document Type: Review

References (39)

1. Pinhas-Hamiel O., Dolan L.M., Daniels S.R., et al. Increased incidence of non-insulin diabetes mellitus among adolescents. J Pediatr 1996, 128:608-615.
2. Dabelea D., Pettitt D.J., Jones K.L., et al. Type 2 diabetes mellitus in minority children and adolescents: an emerging problem. Endocrinol Metab Clin North Am 1999, 28:709-729.
3. Rosenbloom A.L., Young R.S., Joe J.R., et al. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999, 22:345-354.
4. Nathan B.M., Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes 2008, 15:21-29.
5. The Writing Group for the SEARCH for Diabetes in Youth Study Group Incidence of diabetes in youth in the United States. JAMA 2007, 297:2716-2724.
6. Amed S., Daneman D., Mahmud F.H., et al. Type 2 diabetes in children and adolescents. Expert Rev Cardiovasc Ther 2010, 8(3):393-407.
7. Cali A.M., Caprio S. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease?. Curr Opin Endocrinol Diabetes Obes 2008, 15:123-127.
8. Klingensmith G.J., Pyle L., Arslaian S., et al. The presence of GAD and IA-2 antibodies in youth with type 2 diabetes phenotype. Diabetes Care 2010, 33:1970-1975.
9. Grodsky G. The kinetics of insulin release. Handbook of Experimental Pharmacology 1975, vol. 32:1-19. Springer-Verlag, Berlin. A. Hasselblatt, F. Bruchhausen (Eds.).
10. Lee J.M., Okumura M.J., Davis M.M., et al. Prevalence and determinants of insulin resistance among US adolescents. Diabetes Care 2006, 29:2427-2432.
11. D'Adamo E., Caprio S. Type 2 diabetes in youth: epidemiology and pathophysiology. Diabetes Care 2011, 34:S161-S165.
12. Nelson R.A., Bremer A.A. Insulin resistance and metabolic syndrome in the pediatric population. Metab Syndr Relat Disord 2010, 8:1-14.
13. Tfayli H., Arslanian S. Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon. Arq Bras Endocrinol Metabol 2009, 53:165-174.
14. Weiss R., Kaufman F. Metabolic complications of childhood obesity. Diabetes Care 2008, 31:S310-S315.
15. Kursawe R., Cali A., D'Adamo E., et al. Cellularity and adipoegnic profile of the abdominal subcuatbeous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes 2010, 59:288-2296.
16. Danforth E. Failure of adipocyte differentiation causes type II diabetes mellitus?. Nat Genet 2000, 26:13.
17. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106:171-176.
18. Azuma K., Heilbronn L.K., Albu J.B., Look AHEAD Adipose Research Group, et al. Adipose tissue distribution in relation to insulin resistance in type 2 daibetes mellitus. Am J Physiol Endocrinol Metab 2007, 293:E435-E442.
19. McLaughlin T., Sherman A., Tsao P., et al. Enhanced proportion of small adipose cells in insulin-resistant obese individuals vs insulin sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007, 50:1707-1715.
20. Roberts R., Hodson L., Dennis A.L., et al. Markers of de novo lipogenesis in adipose tissue associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009, 52:882-890.
21. Genuth S., Alberti K.G., Bennett P., et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26(11):3160-3167. [review].
22. Sinha R., Fisch G., Teague B., et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002, 346:802-809.
23. Keamseng C, Likitmaskul S, Kiattisathavee P, et al. Risk of metabolic disturbance and diabetes development in Thai obese children, 29th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes. Saint-Malo (France), September 3-6, 2003.
24. Lee W, Tang J, Karim H, et al. Abnormalities of glucose tolerance in severely obese Singapore children, 29th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes. Saint-Malo (France), September 3-6, 2003.
25. Goran M.I., Bergman R.N., Avila Q., et al. Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab 2004, 89(1):207-212.
26. Wiegand S., Maikowski U., Blankenstein O., et al. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity-a problem that is no longer restricted to minority groups. Eur J Endocrinol 2004, 151(2):199-206.
27. Weiss R., Taksali S.E., Tamborlane W.V., et al. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005, 28(4):902-909.
28. Cali A.M., Caprio S. Primary defects in β-cell Function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents. Diabetes Care 2009, 32:456-469.
29. Fleishmann A., Rhodes E.T. Management of obesity, insulin resistance and type2 diabetes in children: consensus and controversy. Diabetes Metab Syndr Obes 2009, 2:185-202.
30. Savoye M., Nowicka P., Shaw M., et al. Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics 2011, 127:402-410.
31. Pinhas-Hamiel O., Zeitler P. Clinical presentation and treatment of type 2 diabetes in children. Pediatr Diabetes 2007, 8(Suppl 9):16-27.
32. Nathan D.M., Buse J.B., Davidson M.B., et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009, 32:193-203.
33. Yanovski J.A., Krakoff J., Salaita C., et al. Effects of metformin on body weight and body composition in obese insulin-resistant children. Diabetes Care 2011, 60:477-485.
34. Jones K.L., Arslanian S., Peterokova V.A., et al. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002, 25:89-94.
35. Burgert T.S., Taksali S.E., Dziura J., et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006, 91:4287-4294.
36. Garnett S.P., Baur L.A., Noakes M., et al. Researching Effective Strategies to Improve insulin Sensitivity in Children and teenagers- RESIST. A randomised control trial investigating the effects of two different diets on insulin sensitivity in young people with insulin resistance and/or pre-diabetes. BMC Public Health 2010, 10:1-10.
37. Svoren B., Wolfsdorf J.I. Management of diabetes mellitus in children and adolescents. Int Diabetes Monitor 2006, 18(5):9-18.
38. Zuhri-Yafi M.I., Brosnan P.G., Hardin D.S. Treatment of type 2 diabetes mellitus in children and adolescents. J Pediatr Endocrinol Metab 2002, 15(Suppl 1):541-546.
39. Gemmill J.L., Brown R.J., Nandagopal R., et al. Clinical trials in youth with type 2 diabetes. Pediatr Diabetes 2011, 12:50-57.